News

Published on 26 Mar 2024 on GuruFocus.com via Yahoo Finance

Mirum Pharmaceuticals Inc (MIRM) Insider Sells Shares

Article preview image

Peter Radovich, President and Chief Operating Officer of Mirum Pharmaceuticals Inc (NASDAQ:MIRM), executed a sale of 4,303 shares in the company on March 25, 2024, according to a recent SEC Filing. The transaction was conducted at an average price of $25.8 per share, leading to a total sale amount of $111,017.4.

Warning! GuruFocus has detected 3 Warning Signs with MIRM.

Read the rest of the article
NASDAQ.MIRM price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What's in the Cards for Viatris Stock This Q4 Earnings?

PCRX beat earnings estimates in two of the trailing four quarters, met once and missed in the oth...

Zacks · via Yahoo Finance 21 Feb 2025
US FDA approves Mirum Pharma's genetic disorder drug

, opens new tab genetic disorder drug on Friday, making it the first treatment for a rare conditi...

Reuters 21 Feb 2025
ADMA Biologics Gears Up to Report Q4 Earnings: What's in the Cards?

On ADMA's fourth-quarter 2024 earnings call, investors are likely to focus on the sales performan...

Zacks · via Yahoo Finance 19 Feb 2025
High Growth Tech Stocks in United States to Watch

The United States market has shown a positive trend, rising 1.2% over the last week and 24% over ...

Simply Wall St. · via Yahoo Finance 19 Feb 2025
Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Path To Profitability

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) is possibly approaching a major achievement in its...

Simply Wall St. · via Yahoo Finance 26 Dec 2024
Shareholders May Be More Conservative With Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) CEO...

Key Insights Mirum Pharmaceuticals' Annual General Meeting to take place on 5th of JuneTotal pay ...

Simply Wall St. via Yahoo Finance 30 May 2024
When Will Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Become Profitable?

With the business potentially at an important milestone, we thought we'd take a closer look at Mi...

Simply Wall St. via Yahoo Finance 28 May 2024
Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of Estimates

Mirum Pharmaceuticals, Inc. MIRM incurred first-quarter 2024 loss of 54 cents per share, wider th...

Zacks via Yahoo Finance 9 May 2024
Mirum reports positive results from LIVMARLI study in PFIC patients By Investing.com

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) recently announced the publication of the Phase 3...

Investing.com 7 May 2024
Mirum Pharmaceuticals Inc (MIRM) Insider Sells Shares

Peter Radovich, President and Chief Operating Officer of Mirum Pharmaceuticals Inc (NASDAQ:MIRM),...

GuruFocus.com via Yahoo Finance 26 Mar 2024

Copyright Statfolio @ 2025

Social Accounts